CVS Health Plans Split Into Two Public Companies by 2028, Shares Fall 12% Despite Earnings Beat

CVS Health said Wednesday it will break itself into two independent, publicly traded companies by the first half of 2028, unwinding the vertically integrated healthcare conglomerate it spent years assembling through deals including the $69 billion Aetna acquisition in 2018.

The stock fell 12.5% on the day, according to Trefis, even as the underlying quarterly numbers cleared the bar. <cite index="23-8">CVS reported adjusted earnings of $2.09 per share, beating Wall Street's estimate of $1.65.</cite> <cite index="23-9">Revenue rose 5.4% year over year to $108.4 billion, topping analysts' estimate of $104.7 billion.</cite> <cite index="26-12">Management also raised its full-year 2026 outlook for adjusted EPS to at least $8.20, from a previous range of $7.90 to $8.10.</cite> The market looked past all of it.

<cite index="22-5,22-6">The stock's premarket drop suggests the market was focused on the company's strategic split, the future earnings mix of the two businesses, and possible separation costs, rather than the earnings beat.</cite>

The structure of the separation, as described in a Form 8-K filed with the SEC on November 4, divides the company along a clear line. <cite index="19-3">One company, retaining the CVS Health name in the interim, will include health insurer Aetna, pharmacy benefit manager CVS Caremark, CVS Specialty, primary care centers Oak Street Health, and health evaluations business Signify Health.</cite> <cite index="19-4,19-5">The other company, to be called CVS Pharmacy, will focus on CVS' 9,000 retail pharmacies, mail pharmacy, MinuteClinic and technology services business Health100.</cite>

<cite index="19-7,19-8,19-9">The two companies will be independent and publicly traded, with CVS expecting the transition to be completed in the first half of 2028 in a transaction intended to be tax-free to CVS and its shareholders for federal income tax purposes.</cite>

Management's explanation from the Q3 earnings call, reviewed via transcript, leaned on operational progress as the rationale. <cite index="27-5">CEO Joyner said the decision to split was made possible by the company's operational and financial progress since 2024.</cite> <cite index="27-6">Both companies are expected to carry solid investment-grade balance sheets and strong free cash flow, enabling tailored capital allocation.</cite>

That's the forward guidance. The harder question is what the split costs. <cite index="22-8,22-9">Separation execution could create costs, complexity and timing risk, and investors may worry the split reduces benefits from the current integrated structure.</cite> <cite index="26-19">Management called the one-time and stranded costs of the split manageable</cite>, without providing a figure on the earnings call.

<cite index="24-7">A separation could also help address regulatory scrutiny of CVS' vertically integrated model, some analysts noted,</cite> a factor management did not emphasize in its own framing.

<cite index="21-5">Management identified 2027 as the expected trough for the Health Services segment earnings, with a return to growth projected thereafter as 340B business dynamics stabilize.</cite> That's worth noting: the company is guiding investors toward a trough year in one of its two new businesses right before the separation closes.

The split lands in an active week for large-cap corporate restructurings. CVS's announcement came the same day the middle-market M&A data service Mergers and Acquisitions reported that October deal volume fell 30% from September, with valuation gaps stalling transactions. The two data points don't contradict each other. Big public companies are still willing to do structural deals when the pressure builds long enough. It took years of insurer losses and retail pharmacy headwinds to get CVS here.

Shares had not recovered the November 4 drop as of Friday's close, per Trefis data showing the stock up 8.9% year to date against the S&P 500's 8.4% gain. The separation timeline gives management roughly 18 months before the market starts holding it to the new structure.

Sources cited:
- CVS Health Form 8-K, SEC Filing, November 4, 2026 (https://www.sec.gov/Archives/edgar/data/0000064803/000119312526446150/d148827dex991.htm)
- CVS Health Q3 2026 Earnings Call Transcript, Motley Fool (https://www.fool.com/earnings/call-transcripts/2026/11/04/cvs-health-cvs-q3-2026-earnings-call-transcript/)
- Benzinga, CVS Health Q3 2026 earnings and breakup report (https://www.benzinga.com/markets/earnings/26/11/62879032/cvs-health-raises-its-outlook-confirms-massive-breakup)
- Trefis, CVS Health Q3 2026 stock analysis (https://www.trefis.com/stock/cvs/articles/623635/what-did-cvs-healths-quarter-change-for-its-stock/2026-11-07)
- NBC News, CVS Health split report via Reuters (https://www.nbcnews.com/business/consumer/cvs-health-split-pharmacy-insurance-rcna607421)
- Investing.com, CVS Health Q3 2026 earnings call transcript (https://www.investing.com/news/transcripts/earnings-call-transcript-cvs-health-beats-q3-2026-estimates-shares-fall-premarket-93CH-4999860)